Skip to main content
Presentation
Secukinumab Provides Rapid and Sustained Pain Relief in Psoriatic Arthritis: 2-year Results from the FUTURE 2 Study. German Society of Rheumatology, (DGRh) 2017, Stuttgart, Germany, September 2017.
German Society of Rheumatology, (DGRh) (2017)
  • I McInnes
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Disciplines
Publication Date
August, 2017
Citation Information
I McInnes, Philip Mease and et.al.. "Secukinumab Provides Rapid and Sustained Pain Relief in Psoriatic Arthritis: 2-year Results from the FUTURE 2 Study. German Society of Rheumatology, (DGRh) 2017, Stuttgart, Germany, September 2017." German Society of Rheumatology, (DGRh) (2017)
Available at: http://works.bepress.com/philip-mease/198/